These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34772528)

  • 21. Discovery of (1
    Wang C; Pei Y; Wang L; Li S; Jiang C; Tan X; Dong Y; Xiang Y; Ma Y; Liu G
    J Med Chem; 2020 Jun; 63(11):6066-6089. PubMed ID: 32421339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
    Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
    Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of small synthetic molecules targeting HBV capsid assembly.
    Liu N; Zhao F; Zhan P; Liu X
    Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and anti-HBV activity of NVR3-778 derivatives.
    Lv K; Wu S; Li W; Geng Y; Wu M; Zhou J; Li Y; Gao Q; Liu M
    Bioorg Chem; 2020 Jan; 94():103363. PubMed ID: 31669092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
    Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
    Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
    Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506.
    Cole AG; Kultgen SG; Mani N; Quintero JG; Yi Fan K; Ardzinski A; Stever K; Dorsey BD; Phelps JR; Lee ACH; Thi EP; Chiu T; Tang S; Horanyi PS; Mayclin SJ; Harasym TO; Sofia MJ
    Bioorg Med Chem Lett; 2023 Oct; 94():129456. PubMed ID: 37633618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents.
    Amblard F; Boucle S; Bassit L; Chen Z; Sari O; Cox B; Verma K; Ozturk T; Ollinger-Russell O; Schinazi RF
    Bioorg Med Chem; 2021 Feb; 31():115952. PubMed ID: 33421915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of 5-alkyl-2-pyrazol-oxazolidin-4-one derivatives as novel hepatitis B virus capsid assembly modulators.
    Guan M; Wang Y; Wang Y; Chen N; Shi S; Sheng R
    Arch Pharm (Weinheim); 2023 Jun; 356(6):e2200592. PubMed ID: 37021586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics.
    Tu J; Li JJ; Shan ZJ; Zhai HL
    Antiviral Res; 2017 Jan; 137():151-164. PubMed ID: 27908829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
    Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
    Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.
    Yin J; Feng Z; Li Z; Hu J; Hu Y; Cai X; Zhou H; Wang K; Tang N; Huang A; Huang L
    Eur J Med Chem; 2023 Mar; 249():115141. PubMed ID: 36709646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.
    Campagna MR; Liu F; Mao R; Mills C; Cai D; Guo F; Zhao X; Ye H; Cuconati A; Guo H; Chang J; Xu X; Block TM; Guo JT
    J Virol; 2013 Jun; 87(12):6931-42. PubMed ID: 23576513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators.
    Wang M; Zhang J; Dou Y; Liang M; Xie Y; Xue P; Liu L; Li C; Wang Y; Tao F; Zhang X; Hu H; Feng K; Zhang L; Wu Z; Chen Y; Zhan P; Jia H
    J Med Chem; 2023 Oct; 66(20):13968-13990. PubMed ID: 37839070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
    Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
    Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.
    Cai CW; Lomonosova E; Moran EA; Cheng X; Patel KB; Bailly F; Cotelle P; Meyers MJ; Tavis JE
    Antiviral Res; 2014 Aug; 108():48-55. PubMed ID: 24858512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay.
    Pei Y; Wang C; Ben H; Wang L; Ma Y; Ma Q; Xiang Y; Zhang L; Liu G
    ACS Infect Dis; 2019 May; 5(5):778-787. PubMed ID: 30761887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.